Daniel D. Thurber »

Halozyme Therapeutics shares owned by Daniel D. Thurber

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Daniel D. Thurber from 13F filings

Historical chart of Daniel D. Thurber investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Daniel D. Thurber consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Daniel D. Thurber

Quarter filed Position value Share count Share price at filing
2026-09-30 $116M 1.0M 110.40

More positions owned by Daniel D. Thurber

Healthequity (HQY)
Ollies Bargain Outlt Hldgs I (OLLI)
Ensign (ENSG)
Global E Online SHS (GLBE)
Medpace Hldgs (MEDP)
Paymentus Holdings Com Cl A (PAY)
Casella Waste Sys Cl A (CWST)
Aaon Com Par $0.004 (AAON)
Kadant (KAI)
Camtek Ord (CAMT)
Skyline Corporation (SKY)
Rli (RLI)
Bbb Foods Cl A Com (TBBB)
CTS Corporation (CTS)
Pjt Partners Com Cl A (PJT)

View all positions for Daniel D. Thurber

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
Invesco
Robeco Investment Management
Bank of America Corporation
Geode Capital Management
William Blair Investment Management
Snyder Capital Management
Congress Asset Management
Dimensional Fund Advisors
D. E. Shaw & Co
Thomas Stevens, CFA"
Royal London Asset Management
Arrowstreet Capital, Limited Partnership

View all funds holding Halozyme Therapeutics